Natural Capsules
180.00
-1.52(-0.84%)
Market Cap₹186.14 Cr
PE Ratio-15.15
IndustryHealthcare
Company Performance:
1D-0.84%
1M-5.14%
6M-18.47%
1Y-27.87%
5Y-27.87%
View Company Insightsright
More news about Natural Capsules
05Aug 25
Natural Capsules Limited Shareholders Approve Key Board Changes and Appointments at 32nd AGM
Natural Capsules' 32nd AGM saw shareholders approve several important resolutions. Mr. Tekkar Yashwanth Prabhu will continue as Non-Executive Independent Director beyond 75 years. Mr. Sathyanarayana Mundra was reappointed as Whole Time Director for three years. Mr. R. Parthasarathy was appointed as Secretarial Auditor for five years. Other approvals included adoption of financial statements, reappointment of Mr. Sushil Kumar Mundra, related party transactions, and commission for Non-Executive Directors. All resolutions passed with overwhelming majority.
04Aug 25
Natural Capsules Reports Mixed Q1 Results: Standalone Profit Amid Consolidated Loss
Natural Capsules reported mixed Q1 financial results. Standalone performance showed growth with Rs 44.24 crore revenue and Rs 2.52 crore net profit. Consolidated results reflected challenges, with Rs 45.20 crore revenue but Rs 5.58 crore net loss. The Capsules segment remained profitable, while the new API segment incurred significant losses. The subsidiary, Natural Biogenex Private Limited, started operations recently and is yet to reach full revenue potential.
Natural Capsules
180.00
-1.52
(-0.84%)
1 Year Returns:-27.87%
Industry Peers
Sun Pharmaceutical
1,698.00
(-1.78%)
Divis Laboratories
6,393.00
(-0.68%)
Torrent Pharmaceuticals
3,960.80
(+0.52%)
Cipla
1,430.10
(-1.26%)
Lupin
2,199.70
(+0.95%)
Dr Reddys Laboratories
1,183.90
(-0.62%)
Mankind Pharma
2,239.30
(+1.15%)
Zydus Life Science
889.25
(-1.27%)
Alkem Laboratories
5,817.00
(-0.79%)
Aurobindo Pharma
1,186.30
(+1.59%)